Company intelligence / Profile preview
Serrix
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
Overview
Serrix is a Netherlands-based consumer healthcare company that develops and markets innovative self-care products and medical devices. The company is best known for its flagship brands, Mycosan and SoreFix, which provide targeted treatments for fungal nail infections and cold sores, respectively. Serrix focuses on creating products with proven clinical efficacy that address common health concerns through user-friendly applications. Their portfolio is distributed internationally through a network of retail and pharmacy partners. By leveraging expertise in regulatory affairs and marketing, Serrix successfully navigates the global OTC landscape to deliver high-quality healthcare solutions.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Device
- Industry
- Pharma
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Serrix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serrix.